CVE-2021-3190

Public Exploit

Description

The async-git package before 1.13.2 for Node.js allows OS Command Injection via shell metacharacters, as demonstrated by git.reset and git.tag.

Category

9.8
CVSS
Severity: Critical
CVSS 3.1 •
CVSS 2.0 •
EPSS 3.04% Top 15%
Third-Party Advisory checkmarx.net Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory github.com Third-Party Advisory github.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://github.com/omrilotan/async-git/pull/13 third party advisory
https://github.com/omrilotan/async-git/pull/13/commits/a5f45f58941006c4cc1699609383b533d9b92c6a third party advisory patch
https://github.com/omrilotan/async-git/pull/13/commits/611823bd97dd41e9e8127c38066868ff9dcfa57a third party advisory patch
https://github.com/omrilotan/async-git/pull/14 third party advisory patch
https://advisory.checkmarx.net/advisory/CX-2021-4772 third party advisory exploit

Frequently Asked Questions

What is the severity of CVE-2021-3190?
CVE-2021-3190 has been scored as a critical severity vulnerability.
How to fix CVE-2021-3190?
To fix CVE-2021-3190, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-3190 being actively exploited in the wild?
It is possible that CVE-2021-3190 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~3% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.